Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits

US Patent 8921318 · Granted Dec 30, 2014

Estimated economic value: $679,000

Assignee

Inventors

View full patent text on Google Patents →